Target Name: COG6
NCBI ID: G57511
Review Report on COG6 Target / Biomarker Content of Review Report on COG6 Target / Biomarker
COG6
Other Name(s): KIAA1134 | complexed with Dor1p 2 | Component of oligomeric Golgi complex 6 | testicular tissue protein Li 41 | COG6 variant 1 | COG6_HUMAN | Component of oligomeric golgi complex 6, transcript variant 2 | SHNS | component of oligomeric golgi complex 6 | COG complex subunit 6 | CDG2L | conserved oligomeric Golgi complex protein 6 | Conserved oligomeric Golgi complex subunit 6 (isoform 2) | COG6 variant 2 | Conserved oligomeric Golgi complex subunit 6 | Conserved oligomeric Golgi complex subunit 6 (isoform 1) | Component of oligomeric golgi complex 6, transcript variant 1 | Conserved oligomeric Golgi complex protein 6 | DKFZp313D191 | COD2 | Complexed with Dor1p 2

COG6: Potential Drug Target Or Biomarker for Various Diseases

COG6 (KIAA1134) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and pancreas. Its function is not well understood, but it is known to be involved in several cellular processes that are important for normal development and maintenance of tissues. Based on this information, COG6 may be a drug target or biomarker for a variety of diseases.

One of the functions of COG6 is its role in cell signaling. COG6 has been shown to be involved in several signaling pathways that are important for normal cellular function. For example, COG6 has been shown to be involved in the TGF-β pathway, a pathway that is important for cell signaling and growth. This pathway is involved in the development and maintenance of tissues, including the brain, and is thought to be involved in the development of several diseases, including cancer.

Another function of COG6 is its role in cell adhesion. COG6 is known to be involved in the formation of tight junctions, which are a type of cell adhesion structure that helps to maintain the integrity of tissues. This is important for the development and maintenance of tissues and is thought to be involved in the development of several diseases, including cancer.

In addition to its role in cell signaling and adhesion, COG6 is also involved in the regulation of cell cycle progression. COG6 has been shown to be involved in the G1 phase of the cell cycle, which is a stage of cell growth and division where DNA replication and protein synthesis occur. This is important for the development and maintenance of tissues and is thought to be involved in the development of several diseases, including cancer.

COG6 may also be involved in the regulation of inflammation. COG6 has been shown to be involved in the production of pro-inflammatory cytokines, which are molecules that play a key role in the regulation of inflammation. This is important for the development and maintenance of tissues and is thought to be involved in the development of several diseases, including cancer.

In conclusion, based on its involvement in several cellular processes that are important for normal development and maintenance of tissues, COG6 may be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its function and the potential implications of its involvement in these diseases.

Protein Name: Component Of Oligomeric Golgi Complex 6

Functions: Required for normal Golgi function

The "COG6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about COG6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

COG7 | COG8 | Cohesin complex | Cohesin loading complex | COIL | COL10A1 | COL11A1 | COL11A2 | COL11A2P1 | COL12A1 | COL13A1 | COL14A1 | COL15A1 | COL16A1 | COL17A1 | COL18A1 | COL18A1-AS1 | COL19A1 | COL1A1 | COL1A2 | COL1A2-AS1 | COL20A1 | COL21A1 | COL22A1 | COL23A1 | COL24A1 | COL25A1 | COL26A1 | COL27A1 | COL28A1 | COL2A1 | COL3A1 | COL4A1 | COL4A2 | COL4A2-AS1 | COL4A3 | COL4A4 | COL4A5 | COL4A6 | COL5A1 | COL5A2 | COL5A3 | COL6A1 | COL6A2 | COL6A3 | COL6A4P1 | COL6A4P2 | COL6A5 | COL6A6 | COL7A1 | COL8A1 | COL8A2 | COL9A1 | COL9A2 | COL9A3 | COLCA1 | COLEC10 | COLEC11 | COLEC12 | COLGALT1 | COLGALT2 | Colipase-Lipase complex | Collagen | Collagen alpha-1(I) chain | Collagen I | Collagen IV | Collagen IX | Collagen V | Collagen VI | Collagen VIII | Collagen XI | Collagenase | Colony-stimulating factor | COLQ | COMETT | COMMD1 | COMMD10 | COMMD2 | COMMD3 | COMMD3-BMI1 | COMMD4 | COMMD5 | COMMD6 | COMMD7 | COMMD8 | COMMD9 | COMP | Complement Complex | Complement component 1q | Complement component C1 | Complement component C8 | COMT | COMTD1 | Condensin complex | Condensin-2 complex | Conserved oligomeric Golgi complex | COP1 | COP9 signalosome complex | COPA | COPB1